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Interaction between intestinal epithelial cells (IECs) and the underlying immune systems is 
critical for maintaining intestinal immune homeostasis and mounting appropriate immune 
responses. We have previously showed that the T helper type 1 (TH1) cytokine IL-12 plays 
a key role in the delicate immunological balance in the gut and the lack of appropriate 
levels of IL-12 had important consequences for health and disease, particularly with 
regard to food allergy. Here, we sought to understand the role of IL-12 in the regulation 
of lymphoepithelial cross talk and how this interaction affects immune responses locally 
and systemically. Using a combination of microscopy and flow cytometry techniques we 
observed that freshly isolated IECs expressed an incomplete, yet functional IL-12 receptor 
(IL-12R) formed solely by the IL-12Rβ2 chain that albeit the lack of the complementary 
IL-12β1 chain responded to ex vivo challenge with IL-12. Furthermore, the expression of 
IL-12Rβ2 on IECs is strategically located at the interface between epithelial and immune 
cells of the lamina propria and using in  vitro coculture models and primary intestinal 
organoids we showed that immune-derived signals were required for the expression of 
IL-12Rβ2 on IECs. The biological relevance of the IEC-associated IL-12Rβ2 was assessed 
in vivo in a mouse model of food allergy characterized by allergy-associated diminished 
intestinal levels of IL-12 and in chimeric mice that lack the IL-12Rβ2 chain on IECs. These 
experimental models enabled us to show that the antiallergic properties of orally delivered 
recombinant Lactococcus lactis secreting bioactive IL-12 (rLc-IL12) were reduced in mice 
lacking the IL-12β2 chain on IECs. Finally, we observed that the oral delivery of IL-12 
was accompanied by the downregulation of the production of the IEC-derived proallergic 
cytokine thymic stromal lymphopoietin (TSLP). However, further analysis of intestinal levels 
of TSLP in IL-12Rβ2−/− mice suggested that this event was not directly linked to the IEC-
associated IL-12Rβ2 chain. We interpreted these data as showing that IEC-associated 
IL12Rβ2 is a component of the cytokine network operating at the interface between the 
intestinal epithelium and immune system that plays a role in immune regulation.
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inTrODUcTiOn
The constant dialog between the intestinal epithelium and under­
lying immune system plays a key role in intestinal immune 
homeostasis by shaping the appropriate immunological microenvi­
ronment (1). Intestinal epithelial cells (IECs) signal to the immune 
system via the secretion of regulatory cytokines; in the presence 
of commensal bacteria, IECs secrete anti­inflammatory molecules 
that include thymic stromal lymphopoietin (TSLP) (2) and trans­
forming growth factor­β (3). By contrast, pathogens cause epithelial 
cells to release proinflammatory factors, such as IL­8 (CXCL­8), 
MCP­1 (CCL2) and MIP­3α (4, 5) and might trigger rapid response 
to clear the infection (6). In turn, cytokines produced by the intesti­
nal immune system may signal back to the epithelium and regulate 
epithelial functions such as, for example, antigen sampling by spe­
cialized M cell (7). The T helper type 1 (TH1) cytokine IL­12 plays 
a variety of roles in intestinal immunity ranging from response to 
pathogens (8), interaction with group 1 innate lymphoid cells in 
maintaining barrier integrity (9) to protecting against food allergy 
(10). With regard to the latter we have previously shown that the 
intestinal levels of IL­12p70 in the gut are critical for the resistance 
to food allergy (10). Indeed, sensitization to the food allergen 
peanuts was characterized by significantly reduced intestinal levels 
of IL­12. One of the most convincing evidence for the regulatory 
role of IL­12 in the intestinal mucosa was brought about by the 
observation that blocking IL­12 in the gut at the time of antigen 
presentation by targeted oral delivery of microencapsulated 
neutralizing antibody significantly increased susceptibility to 
food allergy in mice (10). The notion that IL­12 is critical in food 
allergy is further strengthened by the observation that oral delivery 
of liposome encapsulated IL­12 suppressed allergic reaction (11). 
However, aspects of its mechanism(s) of action remained to be 
determined. We observed that IECs expressed only the low affinity 
IL­12 binding site IL­12Rβ2 chain, but not the complementary 
high affinity binding site IL­12Rβ1 chain. IEC­associated IL­12Rβ2 
operates as an incomplete, yet still operational IL12R the expression 
of which is under the control of immune cell­derived signals. This 
observation prompted us to test the hypothesis that the presence 
of IEC­associated IL­12Rβ2 could directly affect the regulatory 
properties of IECs. This was done by adopting a strategy based 
on oral administration of a Lactococcus lactis strain genetically 
engineered to produce biologically active IL­12 (rLc­IL12) (12) in 
allergic wild­type (wt) and chimeric mice that lacked IL­12Rβ2 on 
the intestinal epithelium. We observed that the lack of IL­12Rβ2 on 
IECs significantly reduced the antiallergy activity of rLc­IL12. Also, 
IL­12 mediated suppression of food allergy was accompanied by 
the downregulation of the IEC­derived cytokine TSLP.
These data suggested that IEC­associated IL­12Rβ2 contributed 
to control the finely tuned regulatory cytokine network operating 
at the lymphoepithelial interface in the gut and impacted on the 
host’s ability to mount appropriate immune responses.
MaTerials anD MeThODs
Mice and Bacterial strain
Mice were maintained in an access­restricted room in con­
ventional conditions. B6.129S1­Il12rb2tm1Jm/J (IL­12Rβ2−/−) 
and wt C57BL/6J mice that were previously used to generate 
chimeric mice (13) were purchased from (Jackson Laboratory, 
Bar Harbor, ME, USA). IL­12Rβ2−/− mice were maintained on 
BL/6 background. Chimeric mice were produced by adopting 
a slightly modified busulfan­based method that allowed a 
stable bone marrow (BM) chimerism (14). Briefly, recipient 
mice were treated with daily injections of 20  mg/kg busulfan 
(6 consecutive days for a total dose of 120  mg/kg busulfan). 
Twenty­four hours after the last BU injection, 5 × 106 BM cells 
collected from the femur and tibia of wt or IL­12Rβ2−/− donors 
and injected i.v. (tail vein) into recipient mice. Age­ and 
sex­matched busulfan­treated IL12Rβ2­deficient mice were 
reconstituted either with BM from wt mice (WT→ IL12Rβ2−/−) 
to generate mice lacking IL­12Rβ2 in IECs (IL­12Rβ2∆IEC) or 
BM from syngeneic IL­12Rβ2­deficient mice (IL­12Rβ2−/− → 
IL­12Rβ2−/−) to control for the effects of the busulfan treat­
ment and BM reconstitution. Mice were then allowed to rest 
for at least 8  weeks before the beginning of the experiments. 
Chimerism was functionally assessed by determining the abil­
ity to produce IFNγ in  vivo following i.p. administration of 
mouse IL­12 (1 μg/mouse for 5 consecutive days) as previously 
described (15). Furthermore, wt C57BL/6J and chimeric mice 
were sensitized according to a well­established model of food 
(peanuts) allergy (10, 16). Ground whole peanuts were used 
as antigen and crude peanut extract (CPE) was prepared as 
described in detail previously (10, 17). Briefly, mice received 
intragastric (i.g.) administration (oral gavage) of 1 mg/mouse of 
ground whole peanut together with 10 µg of cholera toxin (CT) 
(Quadratech Ltd., Surrey, UK) in PBS on days 0, 7, 14, 21 and 
28. On day 35, all mice were challenged by oral gavage with CPE 
(1 mg/mouse divided into two doses at 30 min intervals). The 
administration regimen of the sensitizing mixture was based 
on previously established protocol (10, 16). To assess the role 
of rLc­IL12 in suppressing food allergy, wt and chimeric mice 
were gavaged with PBS (untreated) or L. lactis FI10611 secreting 
bioactive IL­12p70 (rLc­IL12) (8–10 mice/group). Description 
of the wt L. lactis strain, generation of the recombinant IL­12 
producing strain, levels and regulation of IL­12 secretion and its 
biological activity were described by us in detail previously (12). 
Strains were grown to an OD600 of approx 1.0. Cell pellets were 
collected, washed with PBS and resuspended in 2% NaHCO3. 
A suspension of 100 µl containing 109 colony­forming units/ml 
was administrated by oral gavage in a single dose to the mice 
24 and 2  h before administration of the sensitizing mixture. 
The percentage of mice that developed Type I hypersensitivity 
reaction was assessed as previously described (10). Serum levels 
of peanut­specific IgE antibody were determined by ELISA in 
all groups of sensitized and control mice as described previously 
in detail (18). Plasma levels of histamine were detected by using 
an enzyme immunoassay kit (Immunotech S.A.S., Marseille, 
France) whereas the vascular leakage was monitored by measur­
ing the hematocrit. Body temperature was monitored using a 
rectal probe (Kent Scient. Corp. Torrington, USA). Levels of the 
cytokines IL­4 and IL­5 produced by splenocytes in vitro follow­
ing antigen (CPE 20 µg/ml) recall challenge (72 h); plasma levels 
of IFNγ were determined by ELISA kits (ELISA MAX™ Deluxe 
Sets, Biolegend­Cambridge Bioscience, Cambridge, UK).
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gene expression
Total RNA was extracted from gut tissues using RNeasy Mini Kit 
(Qiagen Ltd.). For cDNA synthesis, total RNA was reverse tran­
scribed with Quantitect Reverse Transcription Kit (Qiagen Ltd). 
Q­PCR was performed on 5 µl of diluted (1:5) template cDNA, 
using the ABI 7500 Real­Time PCR System (Applied Biosystems, 
Warrington, UK) and SYBR Green Detection. Data were normal­
ized against an invariant endogenous control, 18S ribosomal 
RNA, and threshold cycle number (Ct) values obtained were 
converted into fold of relative induction using the ΔΔCt. The 
following primers were used: 18s: F CGG ACA GGA TTG ACA 
GAT TG­3′, R 5′­CAA ATC GCT CCA CCA ACT AA; OX40L: F: 
CCC TCC AAT CCA AAG ACT; R: ATC CTT CGA CCA TCG 
TTC; TSLP: F:CCG ATG GGG CTA ACT TAC; R: TCC TGA 
TTT GCT CGA ACT; IL­33: F: GAT GGG AAG AAG CTG ATG 
GTG; R: TTG TGA AGG ACG AAG AAG.
immunohistochemistry and Transmission 
electron Microscopy (TeM)
Frozen sections (8–10 µm) were fixed with 10% buffered formalin 
for 30  min and endogenous peroxidases were quenched with 
0.3% hydrogen peroxide for 1  h and stained with biotinylated 
goat anti­mouse TSLP (R&D Systems) and then treated with 
Vectastain Elite ABC kit (Vector Laboratories). Fluorescein 
deposit was achieved on the site of the immunoreaction with 
the TSA Plus fluorescence system (Perkin­Elmer). Sections were 
counterstained with mouse anti­β­actin Mab (Sigma­Aldrich, 
Milan) followed by TRITC­conjugated donkey anti­mouse IgG 
antibody (Jackson ImmunoResearch Lab­Starfish, Milan, Italy). 
For TEM analysis, tissues were fixed in 4% paraformaldehyde 
and, following dehydration, embedded in Epon 812. Sections 
were incubated overnight at 4°C with rabbit anti­IL12Rβ2 (Bioss 
Inc., Boston, MA, USA) followed by 15 nm gold­conjugated anti­
rabbit IgG (BB International, Cardiff, UK) and examined with a 
201 Philips TE microscope.
isolation of iecs From Mouse small 
intestine and evaluation of il-12r 
expression and Functional integrity
Mice were sacrificed; small intestines were removed, dissected 
longitudinally and washed with sterile PBS. Tissue was cut into 
0.5 cm pieces and washed with sterile PBS. To remove IECs, the 
tissue was subjected to a first wash in PBS containing 10% FCS, 
1 mM DTT (20 ml), and a second wash in PBS containing 10% 
FCS, 15 mM EDTA (20 ml) at 37°C, 250 rpm for 15 and 20 min, 
respectively. Preceding each wash, tissue­buffer mix was vortexed 
for 1 min. After washings the resultant pellets were resuspended 
in PBS containing 10% FCS and stored on ice. CD45+ cells were 
removed from crude IEC preparations using magnetic labeling 
with Anti­PE Microbeads (Miltenyi Biotec) and magnetic separa­
tion with LD MidMACS depletion columns (Miltenyi Biotec). The 
expression and function of IL­12Rβ1 and IL­12β2 chains on viable 
IECs was assessed by flow cytometry. Briefly, isolated IECs were 
double­stained with anti­IL­12Rβ1­FITC and anti­IL­12Rβ2­PE 
or mouse IgG1­PE (R&D Systems) and mouse IgG1­FITC (eBio­
sciences, UK) isotype controls. After incubation for 1 h on ice, cells 
were washed once and pellets were resuspended and fixed with an 
equal volume of 4% formalin for 20 min at room temperature. 
Fixed cells were washed once with PBSA. The functional integrity 
of IL­12Rβ2 through MAPKp38 phosphorylation was tested as 
follows. Freshly isolated IECs were placed in a 37°C water bath in 
the presence of 500 µM H2O2 or 2 µg/ml IL­12 (Biolegend, UK) 
for various times. Control cells were left untreated. At the end of 
the incubation period, an equal volume of 8% buffered formalin 
was added. After 10 min, fixed cells were washed with PBSA and 
allowed to cool on ice; cells were then permeabilized on ice for at 
least 30 min with Perm Buffer III (BD Biosciences, UK). Cells were 
washed and stained for 30 min at room temperature with rabbit 
antiphospho­MAPKp38 (Cell Signaling Technology, Danvers, 
MA, US) or normal rabbit IgG (Senta Cruz Biotechnology, Dallas, 
TX, US) as control. Cells were then incubated for a further 30 min 
with donkey anti­rabbit IgG­FITC (Santa Cruz). For viability 
assessment cells were washed and resuspended in 1 ml PBS. Dead 
cells were stained using Live/Dead Fixable Violet Dead Cell Stain 
Kit (Life Technologies, UK) according to the manufacturer’s 
instructions and data were acquired by flow cytometry.
intestinal Organoids and cell culture
Small intestine organoids were produced according to Sato et al. 
(19). Crypts were counted and diluted to obtain a final concen­
tration of 75,000 crypts/ml. Pelleted crypts were resuspended in 
Matrigel matrix (Corning) (1 ml/75,000 crypts) and 20 µl were 
seeded per well of a preheated (37°C) 48­well tissue culture 
plate (Greiner Bio One). Organoids were grown at 37°C and 
5% CO2 and media was replaced daily. The media used were as 
follows. Small intestinal culture condition (ENR) (19) medium: 
18.4  ml advanced DMEM/F12+++, 0.02% (vol/vol) B27 supple­
ment (Invitrogen), 0.01% (vol/vol) N2 supplement (Invitrogen), 
n­acetylcysteine (final conc. 1.25 mM, Sigma­Aldrich), recom­
binant mouse epidermal growth factor (final conc. 50  ng/ml, 
Invitrogen), recombinant mouse Noggin (final conc. 4  ng/ml, 
Peprotech), recombinant mouse R­spondin (final conc. 1 ng/ml, 
R&D systems) and ROCK kinase inhibitor, y­27632 (final conc. 
10 μM, Sigma­ Aldrich). Advanced DMEM/F12+++ media: 500 ml 
advanced DMEM/F12 (Invitrogen), 1% (vol/vol) Glutamax 100× 
(Invitrogen), HEPES (final conc. 5 mM, Invitrogen) and penicil­
lin (final conc. 100 U/ml)/streptomycin (final conc. 100 µg/ml, 
Invitrogen). In some experiments, conditioned medium (CM) 
from 3­day culture of Peyer’s Patch (PP)­derived immune cells 
was used as part of the culture medium for the development of 
the organoids. Passaging was done after 7 days by breaking the 
Matrigel matrix dome with a 1 ml pipette. The organoids were dis­
sociated from the matrix dome by pipetting with a 200 µl pipette. 
Organoids were centrifuged (600 rcf for 5  min), resuspended 
into fresh Matrigel (ratio 1:3) and seeded as described above. 
MODE­K cells (20) were used to study the influence of immune 
derived­signals on the expression of IL­12Rβ2 on IECs. MODE­K 
cells were seeded in the top compartment of Transwells culture 
system (Costar) at 1  ×  105 cells/well. After 4  days of growth 
PP­derived lymphocytes were added to the culture. Lymphocytes 
were isolated from PPs by mashing between frost edged sterile 
glass slides and filtered through strainer. Following the scraping 
of the MODE­K monolayer, PP­lymphocytes and MODE­K cells 
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were seeded together to the top compartments of the Transwells 
to enable cell­to­cell contact. For non­contact coculture, 1 × 106 
PP­lymphocytes were added to the bottom compartments of 
the Transwell. Expression of IL­12Rβ2 was examined by flow 
cytometry after 72 h.
statistical analysis
The animal study data were analyzed by (ANOVA) Wilcoxon rank 
test. The results for the gene expression data show the average 
relative fold of induction of IL­12Rβ2, TSLP, OX40L and IL­33. 
Data were analyzed using a Student’s t­test (two­tailed, equal 
variance) followed by application of the Bonferroni correction 
the level of which was set at p ≤ 0.0125. In either case, p­value 
of ≤0.05 was considered statistically significant. The results are 
expressed as mean ± SD.
resUlTs
iecs express the il-12rβ2 chain but not 
the complementary il-12rβ1 chain
The TH1 cytokine IL­12 binds to a heterodimeric IL­12Rβ1/β2 
complexes on a variety of immune cells (21). First, flow cytom­
etry analysis was carried out using epithelial cell suspension to 
identify intestinal cells expressing IL­12R. We observed that 
approximately 58% of small intestine CD45− cells and in a 
small proportion (>1%) of CD45+ cells (Figure  1A) expressed 
IL­12Rβ2 chain. IL­12Rβ2 positive cells that did not express 
CD45 (IL­12Rβ2+CD45−) were identified and selected. The 
epithelial origin of the IL­12Rβ2+CD45− cells was confirmed 
through expression of cytokeratin as seen in Figure 1B. Figure 1C 
demonstrated that these IL­12Rβ2+CD45−cytokeratin+ cells did 
not coexpress IL­12Rβ1. Side scatter (SSC) analysis is also shown 
(Figures 1D,E). This showed that the IL­12β2 chain is expressed 
in vivo by IECs in absence of the complementary IL­12Rβ1 chain.
It has been shown that the presence of the IL­12Rβ2 chain is 
indispensable for IL­12 mediated signaling (15) although IL­12Rβ2 
alone was insufficient to induce the canonical signal transducer 
and activator of transcription (Stat) 4 activation in response to 
IL­12 (22). However, an IL­12Rβ1/STAT4­independent pathway 
and based on MAP kinase (MAPK) activation in the presence 
of only the IL­12Rβ2 chain was observed (22). Thus, to assess 
the function of IL­12Rβ2 in the absence of the complementary 
IL­12Rβ1 chain, freshly isolated IECs were cultured in the pres­
ence of IL­12p70 and levels of phospho­MAPK38 were assessed. 
Rapidly, after the application of the stimulus, expression of 
phospho­MAPKp38 reached similar levels observed following 
challenge of IECs with hydrogen peroxide (H2O2) a non­specific 
activation stimulus (Figure 1F). By contrast, IECs isolated from 
IL­12Rβ2−/− mice did not respond to challenge with IL­12p70 dem­
onstrating that activation of MAPK38 was an IL­12Rβ2 specific 
event. The expression of the IL­12Rβ2 chain on IECs was further 
confirmed by TEM by immunogold staining. Positive staining 
was observed within the Golgi area (Figure 2A), in the proximity 
of the basolateral membrane (Figure 2B) and, most relevant to 
lympho­epithelial cross talk, at the interface between IECs and 
immune cells harboring the lamina propria (lp) (Figure 2C).
The expression of il-12rβ2 chain on iecs 
is controlled by immune system-Derived 
signals
The in vivo observation that IL­12Rβ2 was expressed by IECs at the 
interface with local lp­immune cells prompted us to assess whether 
its expression was under the control of immune­derived signals. 
Quantitative RT­PCR analysis showed that the IL­12Rβ2 was 
expressed on freshly isolated primary IECs; however, its expres­
sion was negligible on the murine IEC line MODE­K (Figure 3A). 
By contrast, when using coculture systems (Figure  3B) we 
observed that PP­lymphocytes seeded in the bottom compart­
ment of Transwells culture system induced the expression of the 
IL­12Rβ2 in MODE­K (1.5­fold increase). Yet, a more pronounced 
increase (3.2­fold) was seen when PP­lymphocytes were allowed 
cell­to­cell interaction with the MODE­K cells. The importance 
of immune­derived signals was further investigated in primary 
small intestine organoids that were developed in  vitro. In the 
complete absence of immune cell­derived signals organoids IECs 
lacked the expression of the IL­12Rβ2 chain, however, when the 
organoids were grown in the presence of PP­derived conditioned 
medium (PP­CM) significantly higher number of IL­12Rβ2+ cells 
were observed (Figure 3C; Figure S1 in Supplementary Material). 
This experimental approach also showed that in the presence of 
PP­CM intestinal organoids also tend to increase the expression 
of cytokeratin (Figure S1 in Supplementary Material). Taken 
together these data demonstrated that cross­talk between IECs 
and immune cells is instrumental to trigger the expression of the 
IL­12Rβ2 on IECs.
iec-associated il-12rβ2 chain Plays a 
role in lympho-epithelial cross Talk
To test the biological role of IEC­associated IL­12Rβ2 chain, we 
analyzed the ability of a recombinant bacterial vector secreting 
bioactive IL­12p70 (rLc­IL12) (12) to suppressing food allergic 
response in wt and chimeric IL­12Rβ2−/− and IL­12Rβ2∆IEC 
mice that lack IL­12Rβ2 on IECs. First, we assessed the produc­
tion of IFNγ in response to systemic administration of IL­12 
in IL­12Rβ2−/− mice following BM transplant from wt mice 
(WT→IL­12Rβ2−/−) at week 8 posttransplant. (Figure 4) In agree­
ment with a previous report (15), the presence of an intact IL­12R 
enabled wt mice to produce in vivo significant amount of IFNγ 
following i.p. administration of IL­12. By contrast, IL­12Rβ2−/− 
and chimeric IL­12Rβ2−/− (IL­12Rβ2−/−→IL­12Rβ2−/−) mice 
did not produce detectable levels of IFNγ. However, IFNγ 
production was completely restored in IL­12Rβ2−/− mice by 
BM transplant from wt mice (WT→IL­12Rβ2−/−). The result 
of the functional assay was paralleled by the observation that 
post­BM transplant mice displayed similar levels of MHCII+ 
cells in the lp compared to wt mice (Figure S2 in Supplementary 
Material). Similar results were obtained at week 28 posttrans­
plant (not shown). Taken together these data show a success­
ful BM engraftment. Subsequently we investigated the role of 
IEC­associated IL­12Rβ2 in the regulation of immune response 
using a well­established mouse model of food allergy. The IL­12 
secreting bacterial vector rLc­IL12 was delivered prior to each 
administration of the sensitizing mixture and its effects on food 
FigUre 1 | Expression and functional integrity of IL-12Rβ2 on intestinal epithelial cells (IECs). Flow cytometry analysis was carried out using epithelial cell 
suspension to identify intestinal cells expressing IL-12R. IL-12Rβ2 chain was detected on approximately 50% of small intestine CD45− (IECs) cells and in a small 
proportion (>1%) of CD45+ cells (a). IL-12Rβ2 positive cells that did not express CD45 (IL-12Rβ2+CD45−) were identified and selected. Their epithelial origin was 
confirmed through expression of cytokeratin (B). Furthermore, we showed that the expression of IL-12Rβ2 on these cells was not paralleled by the presence of the 
complementary IL-12Rβ1 chain (c). Also, plots of SSC vs. IL-12Rβ2 are shown (D,e); Cells were stained with PE-coupled isotype control antibody to facilitate 
gating and enable detection of non-specific fluorescence (D). Following staining with PE-coupled anti-IL-12Rβ2 antibody, positive cells were identified (e) within the 
gate R-1 constructed in D above. Finally, ex vivo stimulation of freshly isolated IECs from the mouse small intestine with IL-12p70 led to a rapid increase in 
intracellular phosphorylation of MAPKp38 only in IEC from wt mice but not IL-12Rβ2−/− mice showing that the upregulation of phospho-MAPK38 is an  
IL-12Rβ2-specific event; stimulation with H2O2 was used as a positive control (F). Experiments on MAPKp38 were performed in triplicate using freshly isolated IECs  
(five mice/group). (*) indicates statistical difference. p < 0.05.
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FigUre 2 | Morphological analysis of IL-12Rβ2 on IECs. Transmission 
electron micrograph analysis (immunogold staining) of mouse small intestine 
showed that IL-12Rβ2 in IECs was found in the Golgi (a) as well as the 
basolateral membrane (B) and at the interface between IECs and lymphoid 
cells (c). G, Golgi; EC, epithelial cell; LC, lymphoid cell; m, mitochondria; n, 
nucleus; ic, intracellular space; blm, basolateral membrane; IECs, intestinal 
epithelial cells.
6
Regoli et al. IL-12Rβ2 Chain in the Gut Epithelium
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1177
allergic reaction were monitored upon final allergen challenge 
by monitoring a panel of allergic symptoms. Oral delivery of rLc­
IL12 significantly reduced plasma levels of IgE in sensitized wt 
mice compared to sensitized untreated mice (Figure 5A). Also, 
in these mice we observed that rLc­IL12 prevented the drop in 
temperature associated with allergic reaction following the final 
challenge with the causal allergen (Figure 5B). By contrast, IgE 
response was not affected by the administration of rLc­IL12 in 
chimeric IL­12Rβ2−/− mice (Figure 5C); also, these mice showed 
a markedly higher production of IgE compared to wt throughout 
the allergen sensitization period (summary in Table 1). In this 
group of mice, rLc­IL12 also failed to prevent the allergy­
associated drop in body temperature (Figure 5D). The pattern 
in IL­12Rβ2∆IEC appeared to be different. In this group, the 
administration of rLc­IL12 significantly reduced plasma levels 
of IgE but the magnitude of the reduction was smaller compared 
to wt mice (41 and 93%, respectively) (Figure  5E). A similar 
profile was observed in regard to the effects of rLc­IL12 on body 
temperature (Figure 5F). Here too the treatment with rLc­IL12 
significantly prevented the drop of body temperature observed 
in wt mice but not as much as observed in the wt cohort. A 
similar trend was observed for all the other parameters of Type 
I allergic reactions monitored (Figure 6). Plasma levels of hista­
mine in sensitized wt mice reached 2,100 ± 185 ng/ml and were 
reduced to 320 ± 21 ng/ml (p < 0.01) in rLc­IL12­treated mice 
leading to a 75% reduction (Figure  6A). Furthermore, while 
no effects were seen on histamine levels in IL­12Rβ2−/− mice, 
the administration of rLc­IL12 led to a reduction of plasma 
levels in IL­12Rβ2∆IEC from 2,600 ± 212 to 1,450 ± 104 ng ml 
totaling to a 45% reduction. Treatment with rLc­IL12 also 
affected IL­4 production following in vitro recall antigen chal­
lenge of splenocytes in both wt and chimeric IL­12Rβ2∆IEC but 
not in chimeric IL­12Rβ2−/− mice. Levels of IL­4 in culture 
supernatants following splenocytes challenge with the causal 
allergen were significantly reduced (p  <  0.01) by treatment 
with rLc­IL12 (Figure 6B). By contrast, production of IL­5 was 
downregulated by rLc­IL12 only in wt mice but not in the two 
chimeric groups (Figure 6C). Hematocrit was utilized to moni­
tor vascular permeability leakage, an additional feature of type 
I hypersensitivity reaction (Figure 6D). Hematocrit levels were 
increased in sensitized untreated wt mice (60.5%) compared 
to baseline levels (41.5%) and, in these mice was significantly 
reduced by rLc­IL12 (43.5%). Administration of rLc­IL12 did 
not suppress vascular leakage in chimeric IL­12Rβ2−/− mice, 
however, rLc­IL12 treatment reduced hematocrit levels in 
chimeric IL­12Rβ2∆IEC mice compared to untreated syngeneic 
mice (42.2% and 61.2%, respectively). Finally, we observed that 
the expression of the IL­12Rβ2 on IECs did not differ between 
sensitized and control naïve wt mice (Figures 6E,F) suggesting 
that allergy­associated skewed TH1/TH2 ratio did not affect the 
expression of the IL­12Rβ2 chain on IECs.
Downregulation of iec-Derived TslP 
Following Oral Delivery of rlc-il12 Did  
not Occur Directly via iec-associated 
il-12rβ2
The overexpression of the IEC­derived cytokines TSLP and IL­33 
is critical in food allergy (23–25). We then tested the hypothesis 
that the engagement of IL­12 with the functional IEC­associated 
IL12Rβ2 chain could play a role in the regulation of these proal­
lergic cytokines. First, quantitative RT­PCR analysis (Figure 7A) 
showed that TSLP gene expression was significantly upregulated 
in the gut epithelium of sensitized mice as well as in mice treated 
with CT alone, compared to control non­sensitized (PBS­treated) 
mice. Furthermore, administration of rLc­IL12 led to a significant 
downregulation of TSLP gene expression in the gut epithelium 
of sensitized mice. The regulatory effect of rLc­IL12 on IEC­
derived TSLP was further confirmed by immunohistochemistry. 
The latter approach did not detect TSLP neither in PBS­ nor in 
rLc­IL12­treated mice (Figures 7B,C) but only in sensitized mice 
(Figures  7D,E). Taken together, these results concurred with 
reports that suggested a critical role of the epithelium­derived 
TSLP in allergic reactions (23, 24) and pointed to an important 
role of IL­12 in the regulation of the epithelium­derived TSLP. 
Furthermore, immunofluorescence staining was carried out in 
both IL­12Rβ2−/− and IL­12Rβ2∆IEC chimeric mice undergoing 
allergic sensitization and treated with rLc­IL12. Both sensitized 
chimeric mice retained the ability to produce TSLP by IECs (Figure 
S3 in Supplementary material). The latter observation further sug­
gested that IEC­associated IL­12Rβ2 plays a role in the control of 
TSLP production by IECs. However, when the expression of TSLP 
was assessed in the epithelium of naïve IL­12Rβ2−/− mice we did 
not observe an increase in the level of TSLP compared to naïve wt 
counterparts (Figure 7F). Taken together these data point to a sce­
nario suggesting that IEC­associated IL­12Rβ2 is an important, but 
FigUre 3 | Immune system-derived signal(s) are required for the expression of functional IL-12Rβ2 on intestinal epithelial cells (IECs). Quantitative RT-PCR analysis 
showed that the expression of IL-12Rβ2 was significantly higher on freshly isolated primary IECs compared to cultured intestinal epithelial cell line MODE-K (a). By 
contrast (B), higher expression of IL-12Rβ2 (1.5-fold chance, FC, increase compared IL12Rβ2 expression levels in MODE-K untreated control cells) was seen when 
Peyer’s patch-derived lymphocytes were seeded in the bottom compartment of the Transwells culture system not in contact with MODE-K cells (n-c). However, a 
more pronounced increase (3.2-fold) was seen when PP-lymphocytes were allowed cell-to-cell interaction with the MODE-K cells (c-t-c). Expression of IL-12Rβ2 
was also assessed on primary intestinal organoids developed in culture in the absence (control) or in presence of conditioned medium (CM) from 3-day cultures of 
PP-derived immune cells (PP-CM) chain (c). A significant increase in the number of organoid cells expressed the IL-12Rβ2 was seen when the organoids were 
grown in the presence of CM. Transcript analysis was carried out in replicate mice (five mice/group) in two independent assays. Data were analyzed using a 
Student’s t-test (two-tailed, equal variance) followed by application of the Bonferroni correction the level of which was set at p ≤ 0.0125. Mode-K cells were pooled 
in two independent experiments and samples run in triplicate. Two batches of intestinal organoids/treatment were prepared and samples were run in triplicate.  
The results are expressed as mean ± SD. (*) indicates statistical difference. p < 0.05.
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not the only factor controlling TSLP production by IECs. Overall, 
taken together these data demonstrated that the downregulation 
of IEC­derived TSLP following oral administration of IL­12 is not 
directly linked to IL­12 engagement with the IL­12Rβ2 chain on 
IECs, thus suggesting that IL­12 might trigger the production of 
additional factor(s) that in turn controlled the production of TSLP 
by the intestinal epithelium. Finally, as a corollary parallel analysis 
showed that administration of rLc­IL12 suppressed allergic reac­
tion without downregulating levels of IEC­derived IL­33 while at 
the same time partially suppressing allergy­associated expression 
of OX40L (Figure S4 in Supplementary Material). The latter 
observation pointed to a synergistic action of TSLP and IL­33 
on the expression of the allergy­critical OX40L rather than an 
exclusive role of IL­33 as previously suggested (25).
DiscUssiOn
Here, we report that mouse IECs expressed the IL­12Rβ2 but not 
the complementary IL­12Rβ1 chain that functions as an incom­
plete, yet functional IL­12R that plays a role in lympho­epithelial 
cross talk. In the mouse system, the two β1 and β2 components 
of the IL­12R have specific role in IL­12­mediated binding and 
signaling. IL­12Rβ1 chain is the primary binding site confer­
ring both high and low affinity, instead the IL­12Rβ2 only binds 
IL­12 with low affinity (26). However, these studies carried out 
in IL­12Rβ1−/− mice initially suggested that the β1 component 
was required for both high affinity binding and for immune cells 
response to IL­12 it was later showed that only the IL­12Rβ2 chain 
was strictly required for IL­12 signaling (15). Indeed, no IL­12 
FigUre 4 | Bone marrow (BM) transplant restored in vivo IL-12-mediated 
production of IFNγ in IL-12Rβ2−/− mice. Systemic (i.p.) administration of IL-12 
induced the production of IFNγ by immune cells via IL-12/12R ligation. This 
response was absent in IL-12Rβ2−/− mice; the pattern was different in 
chimeric mice generated by BM transplant from wild-type (wt) mice into 
IL-12Rβ2−/− mice. At week 8 posttransplant the recipient mice that lacked 
IL-12Rβ2 exclusively in intestinal epithelial cells (IECs) (IL-12Rβ2∆IEC) showed a 
physiologic production of IFNγ following ip. administration of IL-12 
demonstrating a successful BM engraftment. By contrast, IL-12Rβ2−/− 
recipients that were transplanted with BM from syngeneic IL-12Rβ2−/− did not 
respond to IL-12 administration. Statistical analysis (seven mice/group) was 
carried out by (ANOVA) Wilcoxon rank test. (*) indicates statistical difference 
p < 0.05.
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mediated biological functions could be detected in IL­12Rβ1+/β2− 
mice. Combined, these studies suggested that in the mouse system 
the IL­12Rβ1 is primarily responsible for binding and IL­12Rβ2 
is further required for IL­12 signaling. Our study extends this 
concept showing that while this is the case for immune cells the 
expression of the sole β2 chain of the IL­12R on IECs might be an 
important component of the lymphoepithelial cross talk.
The expression of IL­12Rβ2 on IECs depended on immune–
derived stimuli. This concept stemmed from several observations. 
A mouse small­intestine derived epithelial cell line and primary 
intestinal organoids cultured in the absence of gut­derived 
immune cells did not express the IL­12Rβ2 chain. By contrast, the 
presence of gut­derived immune cells triggered the expression of 
the IL­12Rβ2 subunit by both an IEC line and primary intestinal 
organoids. This is in line with previous reports showing that the 
expression of the IL­12Rβ2 but not of the IL­12Rβ1 is regulated 
by signals (i.e., cytokines) originating from the immune system 
(22). Although the nature of the signals remains to be determined 
it appeared that both soluble factor(s) and cell­to­cell interaction 
are important to trigger the expression of IL­12Rβ2. This was also 
suggested by the observation that in vivo, the expression of the 
IL­12Rβ2 chain was located at the basolateral domain of IECs at 
the interface with local lp­immune cells.
IL­12 ligation with the conventional IL­12Rβ1/β2 complex 
signaled through the Janus kinase (JAK)­signal transduce pathway 
in both human and mouse (27, 28); in particular, the critical role 
of Stat­4 in IL­12R signaling has been demonstrated in vivo via 
the use of Stat 4­deficient mice (29). On the other hand, although 
in IL­12Rβ1­deficient humans the presence of the sole IL­12Rβ2 
chain was not sufficient to confer full IL­12 responsiveness via 
JAK­mediated pathway, T cells from these individuals could still 
develop into TH1 cells and respond to IL­12 (22). In this case, 
IL­12 signaling occurred via an IL­12Rβ1­independent pathway 
that involved MAPK pathways. In agreement with these observa­
tions, we reported that IL­12/IL­12Rβ2 ligation on freshly isolated 
IL­12Rβ1−/β2+ IECs induced activation of phopho­MAPKp38 in a 
manner similar to that obtained by a non–specific MAPK activa­
tor. At present the possibility that other surface molecules might be 
associated with IL­12Rβ2 on IECs to form an additional variant of 
the IL­12R that operates via MAPK cannot be ruled out; however, 
our results, strongly suggested that the presence of IL­12Rβ2 alone 
on IECs is sufficient to confer responsiveness to IL­12.
The presence of a functional, albeit incomplete IL­12R on IECs 
suggested that the IL­12/IL­12Rβ2 ligation could be important in 
controlling the production by IEC­derived cytokines. We tested 
this hypothesis in a mouse model of food allergy. Its utilization 
was prompted by the notions that in this model the allergic sen­
sitization to food components (peanuts) was characterized by the 
lack of IL­12 in the gut but not in the systemic immune system 
(10); in addition, using the same model others have previously 
shown that oral delivery of liposome encapsulated recombinant 
IL­12 suppressed allergic reaction (11). We report here that in 
chimeric mice the lack of IEC­associated IL­12Rβ2 significantly 
reduced but not completely abolished the antiallergic capability 
of a L. lactis strain genetically engineered to secrete bioactive 
IL­12. This result suggested that IL­12 delivered orally via the 
recombinant bacterial vector produced the antiallergic activity 
by engaging a variety of IL­12 responding cells either locally or 
systemically that included IECs. This result could not be attrib­
uted to an unsuccessful BM engraftment in IL­12Rβ2−/− recipi­
ents; in these mice the production of IFNγ following systemic 
administration of IL­12 was completely restored at 8 weeks after 
transplant of BM from wt mice.
Oral delivery of Lc­IL12 had a significant impact on the levels 
of TSLP produced by IECs in sensitized mice. The production 
of TSLP by IECs is an important example of the importance of 
the tight regulation of the finely tuned cytokine network in the 
gut. On one hand, TSLP plays a critical role in maintaining the 
intestinal immune homeostasis by shaping the anti­inflammatory 
features of dendritic cells (2) and Treg (30); on the other, strong 
evidence suggested that its over­expression is instrumental for the 
development of allergic reactions (23, 24). We found, in agreement 
with another report (25) that mice undergoing the sensitization 
protocol employed in our study displayed a significant increase 
of TSLP production by IECs during and following the sensitizing 
procedure. However, oral administration of rLc­IL12 significantly 
downregulated TSLP production by IECs while at the same time 
supressing allergic symptoms. The action of IL­12 on TSLP pro­
duction however did not appear to be directly linked to the IL­12/
IL­12R ligation on IECs. Naive IL­12Rβ2−/− mice showed only a 
slight increase of IEC­derived TSLP, thus suggesting that the pro­
duction of TSLP by IECs is under the control of multiple factors. 
It is known that the production of certain cytokines, such as IL­13 
required the simultaneous presence of two cytokines (i.e., IL­33 
and IL­7) (31) and this notion lends support to the hypothesis 
that a dual signal might be required also to control the production 
of TSLP by IECs. This would suggest that IL­12 mediated regula­
tion of TSLP production required the synergy with factor(s) that 
FigUre 5 | Effects of oral delivery of rLc-IL12 on IgE levels and body temperature in sensitized wild-type (wt) and chimeric mice. Administration of rLc-IL12 by oral 
gavage in a single dose to wt mice 24 and 2 h before administration of the sensitizing mixture significantly reduced the levels of allergen (peanut)-specific IgE 
antibody (a) and prevented the drop of the body temperature as assessed by rectal probe (B) showing that oral delivery of IL-12 via a genetically engineered strain 
of Lactococcu lactis could suppress food allergic reaction by restoring appropriate levels of IL-12. By contrast, administration of IL-12 in chimeric IL12Rβ2−/− mice 
(BM transplant from IL-12Rβ2−/−→IL-12Rβ2−/−) had no effect. Indeed, neither plasma levels of IgE nor body temperature were affected by treatment with rLc-IL12 
(c,D). The pattern was different in chimeric IL-12Rβ2∆IEC mice (BM transplant from WT→IL-12Rβ2−/−) that lacked the IL-12Rβ2 exclusively on intestinal epithelial cells 
(IECs) (e,F). In these mice, oral delivery of rLc-IL12 afforded a reduced protection against food allergy. Administration of rLc-IL-12 significantly reduced plasma levels 
of IgE compared to rLc-IL12 untreated sensitized mice; however, the extent of the reduction was much less pronounced compared to what was observed in fully 
competent IL-12Rβ2 mice. Similarly, oral administration of rLc-IL12 did not completely abolished the allergy-associated drop in body temperature although the drop 
was significantly (**) less pronounced compared to sensitized rLc-IL12 untreated mice. Statistical analysis (8–10 mice group) was carried out by (ANOVA) Wilcoxon 
rank test. (*, **) indicates statistical differences. p < 0.05.
TaBle 1 | Effects of rLC-IL12 on IgE production (ng/ml): day 35.
group (n = 8/10) reduction control s-Untreated s-rlc-il12 p %
Group I (wt) <10 4,280 ± 950 275 ± 72 <0.001 93.6
Group II (IL-12Rβ2−/−) <10 7,820 ± 1,050 7,250 ± 1,220 >1 8
Group III (IL-12Rβ2βIEC) <10 5,320 ± 980 3,150 ± 650 0.05 41
Levels of plasma IgE were evaluated in wt (Group I) and chimeric mice deficient for IL-12Rβ2 chain (Group II, IL-12Rβ2−/−) or deficient for IL-12Rβ2 chain in intestinal epithelial cells 
(Group III, IL-12Rβ2∆IEC).
Values refer to levels of IgE prior to the beginning of the sensitization period (control) and in mice sensitized and left untreated (s-untreated) or treated with rLC-IL12 (s-rLC-IL12) on 
day 35 following the final antigenic challenge.
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FigUre 6 | Efficacy of rLc-IL12 on additional parameters of food allergy in sensitized wild-type (wt) and chimeric mice. Oral administration of IL-12 reduced levels  
of plasma histamine by 75% in sensitized wt mice compared to IL-12 untreated syngeneic mice (a). By contrast, no effects were seen in chimeric IL-12Rβ2−/− mice; 
instead the IL-12 mediated reduction of plasma histamine in chimeric IL-12Rβ2∆IEC totaled only to 45%. Also, levels of IL-4 produced by splenocytes following in vitro 
recall allergen challenge showed a similar pattern (B). Production of IL-4 in wt mice treated with rLc-IL12 dropped 67% compared to sensitized untreated mice; the 
same treatment was not effective in chimeric IL-12Rβ2−/− mice and only partially effective in IL-12Rβ2∆IEC mice (54%). By contrast, levels of IL-5 following in vitro 
recall allergen challenge were reduced by rLc-IL12 only in wt but not in either chimeric mouse variants (c). Hematocrit was evaluated as a measure of vascular 
leakage (D). Administration of rLc-IL12 restored near physiological levels of hematocrit in wt mice; no effects were seen in chimeric IL-12Rβ2−/− mice and only partial 
restoration of the hematocrit was seen in chimeric IL-12Rβ2∆IEC. Finally, representative histograms showed that levels of IL-12Rβ2 on intestinal epithelial cells (IECs) 
did not vary between sensitized (F) and naïve mice (e). Statistical analysis (8–10 mice group) was carried out by (ANOVA) Wilcoxon rank test. *p < 0.05.
are suppressed/downregulated in sensitized mice but that are still 
retained in non­sensitized IL­12Rβ2−/− mice. Overall, our study 
suggested that IL­12 and TSLP are part of an important regulatory 
cytokine loop operating at the interface between the intestinal 
epithelium and the underlying immune system that ultimately 
plays a role on the host’s ability to mount appropriate immune 
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FigUre 7 | Continued
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responses. Indeed, it has been shown previously that TSLP 
directly suppressed the production of IL­12 in DCs (32); here, we 
report that in turn IL­12, in combination with other factors plays 
a role in controlling the production of TSLP by IECs.
The utilization of a mouse model of food allergy to understand 
the biological role of IL­12Rβ2 in controlling the production of 
IEC­derived cytokines led to the parallel finding that the suppres­
sion of food allergy by IL­12 was indirectly linked to the downreg­
ulation of TSLP but did not affect levels of another allergy­critical 
epithelium­derived cytokine, IL­33. Instead, at the same time oral 
delivery of IL­12 partially suppressed allergy­associated expres­
sion of OX40L. This was rather surprising considering that IL­33 
but not TSLP was previously indicated as having a critical, non­
redundant role in allergy (25). Thus, our work in agreement with 
a recent report (33) argued against the concept that the alteration 
of a single immunoregulatory pathway (i.e., IL­33) is at the core of 
allergic reactions. Our data point to a synergistic action of TSLP 
and IL­33 on OX40L expression, as also more recently shown in a 
rhinovirus­mediated allergic reaction to aeroallergen (34), rather 
than an exclusive IL­33­mediated effect as previously suggested 
(25). In summary, taken together these data show that IL­12Rβ2 
chain functions as an incomplete yet functional IL­12R on IECs 
and overall further highlight the importance of a finely tuned 
lymphoepithelial cross talk in the intestine in maintaining health.
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FigUre 7 | IL-12-mediated downregulation of IEC-derived TSLP does not occur directly via IEC-associated IL-12Rβ2. RT-PCR analysis of the gut epithelium  
(a) showed that oral delivery of the adjuvant cholera toxin (CT) induced a significant increase of TSLP in the gut epithelium similar to that observed following delivery 
of the complete sensitizing mixture (s-untreated) compared to control mice (naive). Allergy-associated levels of TSLP were abrogated by treatment with rLc-IL12. 
This notion was further confirmed by immunohistochemistry. Immunofluorescence analysis with anti-TSLP antibody did not detect levels of TSLP in the IECs of both 
control (B) and rLc-IL12-treated mice (c). In contrast, specific anti-TSLP staining (green) was observed in the epithelium of sensitized rLc-IL-untreated mice  
(D), detail in (e). Sections were counter-stained with antiactin antibody (red). Finally, expression of TSLP gene in the intestinal epithelium of naïve IL-12Rβ2−/− mice 
(F) showed only a minor increase that did not reach statistical significance compared to wt syngeneic mice. In this case, the thymus from wt mice was used as 
positive control. Transcript analysis was carried out in replicate mice (four to six mice/group) in two independent assays. Data were analyzed using a Student’s  
t-test followed by application of the Bonferroni correction the level of which was set at p ≤ 0.0125. (*) indicate statistical difference. p < 0.05.
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